Study highlights pulmonary artery denervation as a key intervention for pulmonary hypertension

Study highlights pulmonary artery denervation as a key intervention for pulmonary hypertension

A recent publication in the International Journal of Cardiology, Pulmonary artery denervation in pulmonary hypertension: A comprehensive meta-analysis, has shed light on the potential of pulmonary artery denervation (PADN) as an innovative intervention for pulmonary hypertension (PH), a condition that places patients at risk for right heart failure and death.

Meta-analysis reveals pulmonary artery denervation as promising intervention for pulmonary hypertension

A recent publication in the International Journal of Cardiology, "Pulmonary artery denervation in pulmonary hypertension: A comprehensive meta-analysis" has shed light on the potential of pulmonary artery denervation (PADN) as an innovative intervention for pulmonary hypertension (PH), a condition that places patients at risk for right heart failure and death. Co-authored by Dr. James Jenkins, a cardiologist at Ochsner Health, the study analyzed…

PAH treatments effective in patients with repaired congenital...

Treatments approved for pulmonary arterial hypertension (PAH) may reduce by half the risk of serious complications or death in adults and adolescents who also have repaired congenital heart disease (CHD), pooled data analysis of three clinical trials shows. This risk was similarly reduced among the whole PAH patient population who participated in the trials and given either Uptravi (selexipag), Opsumit (macitentan), or Tracleer (bosentan). All t…

Pulmonary Edema Symptoms, Causes, Treatment

Pulmonary Edema Pulmonary edema is a serious medical condition that occurs when excess or buildup of fluid begins to fill the air sacs in the lungs (alveoli). When filled with fluid, the alveoli cannot adequately add oxygen, or remove carbon dioxide from the blood. That is why this condition can cause significant breathing difficulties, and potentially be a life-threatening problem. Symptoms of Pulmonary Edema Acute conditions can cause signific…

Breakthrough research revolutionizing pulmonary hypertension treatment

A recent publication in the International Journal of Cardiology, Pulmonary artery denervation in pulmonary hypertension: A comprehensive meta-analysis, has shed light on the potential of pulmonary artery denervation (PADN) as an innovative intervention for pulmonary hypertension (PH), a condition that places patients at risk for right heart failure and death.

Worse CTD-PAH Prognosis Seen With Higher HFA-PEFF Score

The findings from this single-center retrospective study compare outcomes between 2 groups of patients living with connective tissue disease–associated pulmonary arterial hypertension (CTD-PAH) stratified by their Heart Failure Association–preserved ejection fraction (HFA-PEFF) algorithm score.